/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mark Sydenham

Institute of Cancer Research(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

72

Papers

8.2K

Citations

24

h-index

36

i10-index

Mark Sydenham is an academic researcher from Institute of Cancer Research. The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Radiotherapy Techniques & Advances in Oncology and Radiotherapy. The author has an h-index of 24, co-authored 62 publications.

ORCID: 0000-0002-9157-9710

Research Topics

Breast Cancer Treatment Studies Advanced Radiotherapy Techniques Advances in Oncology and Radiotherapy Head and Neck Cancer Studies Viral Infectious Diseases and Gene Expression in Insects

Papers by this author

works

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

2011 · The Lancet Oncology · 1,665 citations

https://doi.org/10.1016/s1470-2045(10)70290-4

Christopher M. Nutting James P. Morden Kevin J. Harrington Teresa Guerrero Urbano

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

2020 · The Lancet · 1,018 citations

https://doi.org/10.1016/s0140-6736(20)30932-6

Adrian Murray Brunt Joanne Haviland Duncan Wheatley Mark Sydenham

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

2020 · The Lancet · 1,018 citations

https://doi.org/10.1016/s0140-6736(20)30932-6

Adrian Murray Brunt Joanne Haviland Duncan Wheatley Mark Sydenham

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

2016 · Radiotherapy and Oncology · 221 citations

https://doi.org/10.1016/j.radonc.2016.02.027

Adrian Murray Brunt Duncan Wheatley John Yarnold Navita Somaiah

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials

2017 · Radiotherapy and Oncology · 101 citations

https://doi.org/10.1016/j.radonc.2017.10.033

Joanne Haviland Mariella Mannino Clare Griffin Núria Porta

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial

2023 · The Lancet Oncology · 93 citations

https://doi.org/10.1016/s1470-2045(23)00265-6

Christopher M. Nutting Laura Finneran Justin Roe Mark Sydenham

Research topics

topics

Breast Cancer Treatment Studies

Advanced Radiotherapy Techniques

Advances in Oncology and Radiotherapy

Head and Neck Cancer Studies

Viral Infectious Diseases and Gene Expression in Insects

Chat about Author

Papers

Chat

Click to start Chat